337 related articles for article (PubMed ID: 29887176)
41. Predictors for blood loss and transfusion frequency to guide blood saving programs in primary knee- and hip-arthroplasty.
Pempe C; Werdehausen R; Pieroh P; Federbusch M; Petros S; Henschler R; Roth A; Pfrepper C
Sci Rep; 2021 Feb; 11(1):4386. PubMed ID: 33623079
[TBL] [Abstract][Full Text] [Related]
42. Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study.
Rineau E; Chaudet A; Chassier C; Bizot P; Lasocki S
Transfusion; 2016 Mar; 56(3):673-81. PubMed ID: 26748489
[TBL] [Abstract][Full Text] [Related]
43. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety.
Poeran J; Rasul R; Suzuki S; Danninger T; Mazumdar M; Opperer M; Boettner F; Memtsoudis SG
BMJ; 2014 Aug; 349():g4829. PubMed ID: 25116268
[TBL] [Abstract][Full Text] [Related]
44. Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty.
Noordin S; Waters TS; Garbuz DS; Duncan CP; Masri BA
Clin Orthop Relat Res; 2011 Feb; 469(2):541-6. PubMed ID: 20574802
[TBL] [Abstract][Full Text] [Related]
45. Intravenous Tranexamic Acid Bolus plus Infusion Is Not More Effective than a Single Bolus in Primary Hip Arthroplasty: A Randomized Controlled Trial.
Zufferey PJ; Lanoiselée J; Chapelle C; Borisov DB; Bien JY; Lambert P; Philippot R; Molliex S; Delavenne X;
Anesthesiology; 2017 Sep; 127(3):413-422. PubMed ID: 28692467
[TBL] [Abstract][Full Text] [Related]
46. Relative efficacy of tranexamic acid and preoperative anemia treatment for reducing transfusions in total joint arthroplasty.
Styron JF; Klika AK; Szubski CR; Tolich D; Barsoum WK; Higuera CA
Transfusion; 2017 Mar; 57(3):622-629. PubMed ID: 27987219
[TBL] [Abstract][Full Text] [Related]
47. Tranexamic Acid Plus Low-dose Epinephrine Reduces Blood Loss in Total Knee Arthroplasty: A Systematic Review and Meta-analysis.
Wu YG; Zeng Y; Hu QS; Bao XC; Xiong HZ; Shen B
Orthop Surg; 2018 Nov; 10(4):287-295. PubMed ID: 30406972
[TBL] [Abstract][Full Text] [Related]
48. Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement.
Sepah YJ; Umer M; Ahmad T; Nasim F; Chaudhry MU; Umar M
J Orthop Surg Res; 2011 May; 6():22. PubMed ID: 21600028
[TBL] [Abstract][Full Text] [Related]
49. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
[TBL] [Abstract][Full Text] [Related]
50. The Effect of Preoperative Administration of Intravenous Tranexamic Acid During Revision Hip Arthroplasty: A Retrospective Study.
Peck J; Kepecs DM; Mei B; Safir OA; Backstein D; Gross AE; Kuzyk PR
J Bone Joint Surg Am; 2018 Sep; 100(17):1509-1516. PubMed ID: 30180060
[TBL] [Abstract][Full Text] [Related]
51. Implementation of tranexamic acid reduces red blood cell utilization in orthopedic surgeries.
Kaplan A; Wisniewski M; Waters JH; Yazer MH
Transfusion; 2019 Sep; 59(9):2774-2775. PubMed ID: 31211427
[No Abstract] [Full Text] [Related]
52. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.
Kelley TC; Tucker KK; Adams MJ; Dalury DF
Transfusion; 2014 Jan; 54(1):26-30. PubMed ID: 23521109
[TBL] [Abstract][Full Text] [Related]
53. [Implementation of blood sparing programs in Spain: results of a survey of departments of anesthesiology and resuscitation].
Colomina MJ; Basora Macaya M; Bisbe Vives E
Rev Esp Anestesiol Reanim; 2015 Jun; 62 Suppl 1():3-18. PubMed ID: 26320339
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial.
Camarasa MA; Ollé G; Serra-Prat M; Martín A; Sánchez M; Ricós P; Pérez A; Opisso L
Br J Anaesth; 2006 May; 96(5):576-82. PubMed ID: 16531440
[TBL] [Abstract][Full Text] [Related]
55. Prevention of post-operative anaemia in hip and knee arthroplasty--a systematic review.
Khan N; Troelsen A; Husted H
Dan Med J; 2015 Dec; 62(12):A5170. PubMed ID: 26621400
[TBL] [Abstract][Full Text] [Related]
56. Periarticular Injection of Tranexamic Acid Reduces Blood Loss and the Necessity for Allogeneic Transfusion After Total Knee Arthroplasty Using Autologous Transfusion: A Retrospective Observational Study.
Yozawa S; Ogawa H; Matsumoto K; Akiyama H
J Arthroplasty; 2018 Jan; 33(1):86-89. PubMed ID: 28927562
[TBL] [Abstract][Full Text] [Related]
57. A protocol avoiding allogeneic transfusion in joint arthroplasties.
Suh YS; Nho JH; Choi HS; Ha YC; Park JS; Koo KH
Arch Orthop Trauma Surg; 2016 Sep; 136(9):1213-1226. PubMed ID: 27450193
[TBL] [Abstract][Full Text] [Related]
58. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement.
Lemay E; Guay J; Côté C; Roy A
Can J Anaesth; 2004 Jan; 51(1):31-7. PubMed ID: 14709457
[TBL] [Abstract][Full Text] [Related]
59. Tranexamic Acid Reduces Blood Transfusions in Revision Total Hip Arthroplasty.
Park KJ; Couch CG; Edwards PK; Siegel ER; Mears SC; Barnes CL
J Arthroplasty; 2016 Dec; 31(12):2850-2855.e1. PubMed ID: 27426220
[TBL] [Abstract][Full Text] [Related]
60. Low blood transfusion rate after implementation of tranexamic acid for fast- track hip- and knee arthroplasty. An observational study of 5205 patients.
Bemelmans Y; Van Haaren E; Boonen B; Hendrickx R; Schotanus M
Acta Orthop Belg; 2021 Mar; 87(1):9-16. PubMed ID: 34129752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
